The eraser enzyme, FTO, promotes melanoma tumorigenesis and resistance to immunotherapy, while decreased FTO expression increased IFNy-induced tumor cell killing and promoted beneficial PD-1 immunotherapy [104]. Here, FTO is linked to neoplasm.